2015). Cranberry (Vaccinium macrocarpon) oligosaccharides decrease biofilm formation by uropathogenic ABSTRACT 1 The preventive effects of the American cranberry (Vaccinium macrocarpon) 2 against urinary tract infections are supported by extensive studies which have 3 primarily focused on its phenolic constituents. Herein, a phenolic-free 4 carbohydrate fraction (designated cranf1b-F2) was purified from cranberry fruit 5 using ion exchange and size exclusion chromatography. MALDI-TOF-MS 6 analysis revealed that the cranf1b-F2 constituents are predominantly 7 oligosaccharides possessing various degrees of polymerisation and further 8 structural analysis (by GC-MS and NMR) revealed mainly xyloglucan and 9
generally easy to treat with antibiotics, acute infections can be dangerous for 25 elderly, infant and immunocompromised patients (Jepson, Williams, & Craig, 26 2012). Some UTI patients can experience frequent recurrent infections and 27 increased susceptibility to drug resistant uropathogens (Jepson et al., 2012;  28 Reid et al., 2001) . Over 80% of UTIs are associated with Escherichia coli, which 29 may be transmitted from the bowel to urethra. Biofilms that form on the 30 bladder wall help prevent the bacteria from being eradicated by the immune 31 system and antibiotics (Anderson et al., 2003; Moreno et al., 2008) . Evidence 32 suggests that consumption of the American cranberry (Vaccinium macrocarpon 33 Aiton) juice can inhibit the presence of bacteria in urine and reduce UTI 34 symptoms associated with bacteriuria and pyuria (Avorn et al., 1994; Reid et 35 al., 2001) . Our group (LaPlante, Sarkisian, Woodmansee, Rowley, & Seeram, 36 2012), and others (Côté et al., 2011; Iswaldi et al., 2012; Lian, Maseko, Rhee, 37 & Ng, 2012) have studied the antimicrobial effects of the phenolic constituents 38 of cranberries. Some studies (Foo, Lu, Howell, & Vorsa, 2000a , 2000b Gupta 39 et al., 2012; Howell et al., 2005) have shown that cranberry proanthocyanidins 40 (commonly known as PACs), with at least one A-type linkage, inhibit the 41 adherence of type p-fimbriated E. coli to uroepithelial cells and human red blood 42 cells. The chemistry of cranberry PACs (Lee, 2013) and their absorption and 43 4 metabolism have been studied (Ou & Gu, 2014) . However, the non-phenolic 44 constituents in cranberry have been less investigated (Hotchkiss, Nunez, Khoo, 45 & Strahan, 2013) . Herein, we provide the first report describing the structural 46 characterization of a phenolic-free carbohydrate fraction purified from cranberry 47 and its evaluation for inhibition of biofilm formation by both uropathogenic (E. In this study, we investigated a carbohydrate fraction extracted from cranberry 150 and evaluated its inhibitory effect on biofilm formation of two strains of E. coli.
151
The 1 H NMR spectra of the original cranberry starting material (Cranf1) and its 152 three major purified fractions namely, Cranf1W, Cranf1b and Cranf1M were Fig. S6 ) and the average molecular size was predicted 163 to be 1370 Da. However, MALDI-TOF MS spectrometry of cranf1b-F2 produced 164 a series of oligosaccharide sodium adduct ions ( Supplementary Fig. S7 ),
165
revealing it to be a mixture of oligomers within a close molecular weight range.
166
The ions at approximately 1055, 1085, 1217, 1247, 1349, 1379, 1511, 1541 can 167 be attributed to Hex3Pen4 (5 hexoses and 4 pentoses), Hex4Pen3, Hex4Pen4,
168
Hex5Pen3, Hex4Pen5, Hex5Pen4, Hex5Pen5 and Hex6Pen4, respectively.
169
Clusters of less abundant ions were observed above 1700 representing 170 oligosaccharides with degrees of polymerisation (DP) larger than 11.
172
The GC-MS profile ( Supplementary Fig. S8a) Glycosyl linkages of each monosaccharide are listed in Table 1 (GC-MS profile   180 see Supplementary Fig. S8b ). In addition to the common glycosyl linkages 181 known for xyloglucan (Fry et al., 1993 ) 5-α-Arab, 3-α-Arab and 3,5-α-Arab were 182 also found in cranf1b-F2. These additional linkages are consistent with 183 arabinan side chains that are commonly present in cell-wall pectic substances 184 (Caffall & Mohnen, 2009 introduced by Albersheim and coworkers in 1973 (Keegstra, Talmadge, Bauer, 199 & Albersheim, 1973) . Thompson and Fry (Thompson & Fry, 2000) observed Fry, 2005; Thompson & Fry, 2000) . However, no NMR spectroscopic evidence 208 for a covalent linkage has yet been reported. In our study, co-elution of the 209 xyloglucan and arabinan components of cranf1b-F2 in every chromatography 210 step, coupled with its slight acidity, (Thompson & Fry, 2000) suggests the 211 existence of a covalent linkage.
213
The original cranberry material (Cranf1) and its three major purified fractions, 214 namely, Cranf1W, Cranf1b and Cranf1M were tested for the prevention of 215 biofilm formation against E. coli MG1655, a non-uropathogenic strain, and E. 216 coli CFT073, a well-studied uropathogenic strain (Welch et al., 2002 ) (see Table   217 S1, Supplementary data). At equivalent concentrations (1.25 mg/mL), Cranf1b 218 showed the most reduction in biofilm formation against the uropathogenic E. 219 12 coli CFT073 strain, therefore its sub-fractions, Cranf1b-F1 and cranf1b-F2 were 220 further tested against this strain. Although no activity was observed for cranf1b-221 F1, cranf1b-F2 reduced biofilm formation of E. coli CFT-073 by as much as 50 % 222 at 1.25 mg/mL after 6 h of incubation (Figure 2a ). The reductive effect on 223 biofilm formation was maintained for at least 48 h (Figure 2a ) with no growth 224 inhibition, demonstrating that the reduced biofilm after 6 h is not merely due to 225 a delay in the initiation of biofilm production. Interestingly, the highest 226 inhibitory effect was not achieved at the highest concentration tested. While the 227 reason for the declining prevention at higher concentration is not yet known, we 228 hypothesise that aggregation of the cranf1b-F2 sample may be partially 229 responsible. HPSEC analysis showed that large particles (>100,000 Da) 230 formed at the higher concentration ( Supplementary Fig. S6 ). Aggregation of As previously discussed, the role of the polyphenols (including PACs) present 243 in cranberries in its preventive effects against urinary tract infections has been 244 extensively studied by several groups (LaPlante, Sarkisian, Woodmansee,
245
Rowley, & Seeram, 2012; Gupta et al., 2012; Howell et al., 2005) . Thus, it is 246 possible that the multiple constituents, including polyphenols and 247 oligosaccharides, present in the cranberry whole fruit act additively, 248 complementarily, and/or synergistically in its overall biological effects.
249
Interestingly, in the current study, we did not observe any growth inhibitory and 250 anti-biofilm effects of the Cranf1M fraction (which was enriched in polyphenol 251 constituents) on both of the E. coli strains which was in agreement with our 252 previous report (LaPlante, Sarkisian, Woodmansee, Rowley, & Seeram, 2012) .
253
Therefore, while it appears that the phenolic constituents did not contribute to 254 the inhibition of biofilm formation by the uropathogenic E. coli CFT073 strain 255 (based on our bioassays), their overall contribution to the prevention of urinary 256 tract infections by the whole cranberry fruit should not be discounted. 
